A third Russian vaccine against the coronavirus should enter civilian circulation in the next few months, Russian Prime Minister Mikhail Mishustin said at a session of the presidium of the state coordination council to control the coronavirus incidence in the Russian Federation on Tuesday.
“The Healthcare Ministry received paperwork for registration of yet another vaccine by the Chumakov Center, this is already a third product by our scientists,” he noted.
“In the next few months, it will also enter civilian circulation. This will allow expanding inoculation, making it more accessible, which means protecting even more people against the coronavirus,” he explained.
The prime minister reiterated that currently the Sputnik V preparation is predominantly used in the mass inoculation.
“Next month, we will move on to a large-scale production of the EpiVacCorona vaccine. It has already begun to enter civilian circulation. The government allocated over 2 bln rubles [over $26 mln – TASS] for its production,” he added.
The prime minister emphasized that the inoculation has just begun and time should elapse before herd immunity is developed. “That is why it is necessary to continue to observe precautionary measures in order to protect yourself and your loved ones from the infection,” he reiterated.
The Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences has submitted documents for registration of its anti-coronavirus vaccine, Covi-Vac.
The Center has developed its own dead whole-virion vaccine against the novel coronavirus infection. Whole-virion vaccines are based either on artificially weakened viruses incapable of causing a disease or killed (inactivated) viruses.
The vaccine is expected to be registered on February 16.
The Chumakov Center was created on the basis of the Institute of Poliomyelitis and Virus Encephalitis of the USSR. Today the Chumakov Center is a leading world research organization in the sphere of medical virology.